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Abstract
Background: The introduction of electronic transfer of prescriptions (ETP) or ePrescriptions in
ambulatory health care has been suggested to have a positive impact on the prescribing and
dispensing processes. Thereby, implying that ePrescribing can improve safety, quality, efficiency, and
cost-effectiveness. In December 2007, 68% of all new prescriptions were transferred electronically
in Sweden. The aim of the present study was to assess the quality of ePrescriptions by comparing
the proportions of ePrescriptions and non-electronic prescriptions necessitating a clarification
contact (correction, completion or change) with the prescriber at the time of dispensing.
Methods: A direct observational study was performed at three Swedish mail-order pharmacies
which were known to dispense a large proportion of ePrescriptions (38–75%). Data were gathered
on all ePrescriptions dispensed at these pharmacies over a three week period in February 2006. All
clarification contacts with prescribers were included in the study and were classified and assessed
in comparison with all drug prescriptions dispensed at the same pharmacies over the specified
period.
Results: Of the 31225 prescriptions dispensed during the study period, clarification contacts were
made for 2.0% (147/7532) of new ePrescriptions and 1.2% (79/6833) of new non-electronic
prescriptions. This represented a relative risk (RR) of 1.7 (95% CI 1.3–2.2) for new ePrescriptions
compared to new non-electronic prescriptions. The increased RR was mainly due to 'Dosage and
directions for use', which had an RR of 7.6 (95% CI 2.8–20.4) when compared to other clarification
contacts. In all, 89.5% of the suggested pharmacist interventions were accepted by the prescriber,
77.7% (192/247) as suggested and an additional 11.7% (29/247) after a modification during contact
with the prescriber.
Conclusion: The increased proportion of prescriptions necessitating a clarification contact for
new ePrescriptions compared to new non-electronic prescriptions indicates the need for an
increased focus on quality aspects in ePrescribing deployment. ETP technology should be
developed towards a two-way communication between the prescriber and the pharmacist with
automated checks of missing, inaccurate, or ambiguous information. This would enhance safety and
quality for the patient and also improve efficiency and cost-effectiveness within the health care
system.
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Background
The introduction of electronic transfer of prescriptions
(ETP), or ePrescriptions, in ambulatory health care has
been suggested to have a positive impact on the prescrib-
ing and dispensing processes implying that ePrescribing
can improve safety, quality, efficiency and cost-effective-
ness [1-10].
For hundreds of years, the handwritten prescription has
been the method of choice for the physician to communi-
cate decisions on drug therapy and for the pharmacist to
dispense the medication. At the same time, it has acted as
a source of information for the patient about how to use
the medication in order to maximize its benefit. Regula-
tion of the written prescriptions used by apothecaries in
dispensing drugs appeared in one of the earliest known
statutes on the control of drugs [11]. Over the following
centuries, both the "recipe" for drug composition and the
dispensing of medications at pharmacies became more
and more tightly regulated and became subject to inspec-
tion by the authorities in order to ensure quality for the
patient. Dispensing pharmacists are now obliged to exam-
ine all prescriptions for accuracy, completeness and cor-
rectness. However, the handwritten prescription has a
number of well-recognized weaknesses. Namely, varying
readability and interpretation of the prescriber's hand-
writing, the risk of falsification, unidirectional communi-
cation with no feedback and the lack of easily
understandable information for the patient. Currently,
drug prescribing is at a transitional stage and the adapta-
tion of a traditional process to the new electronic era
offers unique challenges.
ETP technology was first deployed in 1983 in an outpa-
tient setting with electronic communication being set up
between the computer systems at a doctor's office at the
medical clinic and those at a nearby pharmacy in
Jönköping, Sweden. The collaboration resulted in the
world's first electronically transferred prescription in an
outpatient setting [12-14]. In 1984, Swedish authorities
regulated the ETP for the first time, including the test
package and dose schedule/time period prescribing fea-
tures [15]. In short, the new regulation made it legal for
pharmacists to dispense an electronically transferred pre-
scription with local agreements regulating the responsibil-
ity for the sending and the receiving professionals. By
making their computer systems available for ePrescrip-
tions, the dispensing pharmacists were made responsible
for the quality and safety of ePrescriptions.
Since then, prescription software, including both systems
integrated with electronic health care records (EHR) and
web-based stand-alone systems, has been developed, mar-
keted and implemented and is currently being introduced
on a broad scale within health care. In recent years, in
countries such as Sweden, Denmark and the US, consider-
able efforts have been made towards the wide scale imple-
mentation of ePrescribing [4,16-18].
The development of ePrescriptions in Sweden has acceler-
ated rapidly since a new strategy with collaborative
national and regional implementation teams was intro-
duced at the end of the 1990s (Figure 1). The new strategy
prioritized the implementation of ePrescriptions among
all stakeholders in a coordinated way to reach a penetra-
tion rate of at least 80%. By the end of 2007, the actual
penetration rate of ETP was as high as 68% of all new pre-
Trends in transferred ePrescriptions in Sweden where the first ePrescription was launched in 1983 [16] Figure 1
Trends in transferred ePrescriptions in Sweden where the first ePrescription was launched in 1983 [16]. In 
December 2007, 68% (inter-county range 46–85%) of all prescriptions were electronically transferred with a steadily growing 
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scriptions (unpublished observations Apoteket AB,
December, 2007). A national ePrescription communica-
tion exchange hub with a virtual repository, called the
national mail box for prescriptions, allows the patient to
access their prescriptions at any pharmacy on presentation
of valid identification.
However, the introduction of new technologies such as
ePrescribing may create new errors, both systematic and
non-systematic, in the prescribing and dispensing proc-
esses [19,20]. Stored ePrescription information may be
used not only for filling the actual prescription but also
for future clinical decision making and epidemiological
research. Thus, it is vital to systematically monitor the
quality of the electronic prescribing process [21,22].
Aim of the study
The aim of the present study was to assess the quality of
ePrescriptions by comparing the proportions of ePrescrip-
tions and non-electronic prescriptions necessitating a clar-
ification contact (correction, completion or change) with
the prescriber at the time of dispensing.
Methods
Type of study
The study was a prospective, direct, observational study.
Data was collected by trained observers (pharmacy stu-
dents) using a specifically designed protocol. Ethical
approval was not sought for the study.
Study period
The study was conducted over a three week period (15
weekdays) in February–March 2006 at three mail-order
pharmacies (MOP) in Sweden.
Setting
Four Swedish MOPs were invited to participate and one
MOP subsequently declined. The three remaining MOPs
were chosen as study settings as they all handle prescrip-
tions for non-pharmacy outlets (about 900) in remote
areas. In addition, they serve pharmacy customers directly
via mail-order. Non-pharmacy outlets are general food
stores and other establishments that are not staffed by
pharmacists. They deliver pharmaceuticals in sparsely
populated areas as representatives for the pharmacies. The
MOPs also had a relatively large proportion (range 38–
75%) of ePrescriptions at the time of the study. The same
regulations and operating procedures apply to the MOPs
as to the other community pharmacies (about 900) in
Sweden. However, unlike their colleagues at other phar-
macies, pharmacists at the mail-order pharmacies cannot
communicate with the patient 'face-to-face' at the phar-
macy counter. In addition, since they handle prescriptions
from prescribers who may not be in the same neighbor-
hood, they generally do not have personal knowledge of
the physicians' prescribing habits. Pharmacies in Sweden
do not have access to automated software for prospective
drug utilization reviews (pDUR). For example, drug inter-
actions and contraindications [23-25]. All prescriptions in
the present study were manually examined by the phar-
macists.
Inclusion and exclusion criteria
The study included prescriptions with prescription errors,
ambiguities, or other problems related to drug prescrip-
tions for humans with a Swedish civic number where the
pharmacist judged it necessary to make a contact with the
prescriber prior to dispensing for clarification, correction,
completion, or change. All attempts to contact the pre-
scriber were included in the study regardless of whether
they resulted in a contact during the study period. Pre-
scriptions for non-pharmaceuticals (syringes, compres-
sion stockings, dressings) or for animals were excluded.
Definition of ePrescriptions
ePrescriptions were defined as personal prescriptions of
drugs for humans electronically transferred from the pre-
scriber's computer system to a national ePrescription mail
box which is accessible to all Swedish pharmacies. At the
time of the study, ePrescriptions with refills were handled
and recorded as ePrescriptions only at the first dispensing
occasion. Prescriptions faxed or merely printed on paper
by a computer system were not defined as ePrescriptions.
Work organization
At all three settings, prescriptions were prepared in a two-
step process. Prescribing problems detected in the pre-
scription preparation line were transferred to a second
line where a pharmacist at a phone desk was available to
investigate the problem and make contact with the pre-
scriber if clarification was required. Some of the prescrip-
tion problems may have been resolved by the pharmacists
themselves after consulting the patient or the patient's rel-
atives by phone or by means of other information sources.
All contacts with the prescribers were made by the phar-
macist at the phone desk. The prescribers were not noti-
fied of the study.
Data collection
The observers closely followed the pharmacists at the
phone desk, recording all attempts to make contact with
prescribers. A copy of the prescription was attached to the
protocol form (See Additional file 1). The observations
were recorded and classified according to an internation-
ally developed protocol which was translated into Swed-
ish and modified for the Swedish context [26,27].
Validation of classification
Examination and supervision of the data classification
were performed by one of the authors (AE). Any irregular-BMC Medical Informatics and Decision Making 2009, 9:8 http://www.biomedcentral.com/1472-6947/9/8
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ities in classification were discussed with the observers to
achieve consensus and consistency.
Statistics
The collected data were transferred to electronic form in
Microsoft Access® and then exported to Microsoft Excel®
for cross tabulation.
The outcome measures (numbers and frequencies of pre-
scriptions necessitating a clarification contact, causes of
clarification contacts, time and results of interventions)
were related to statistics on dispensed prescriptions
obtained from Apoteket AB (personal communication B-
M Alsén) for February 2006 for the three pharmacies stud-
ied. These statistics were adjusted for number of workdays
(15/20) as the study covered a different time period (15
workdays) to the collected statistics (20 workdays). Rela-
tive risks (RRs) with 95% confidence intervals (95% CIs)
were used to compare rates between the two groups ePre-
scriptions and non-ePrescriptions. RRs and 95% CIs were
calculated using Episheet http://ken.rothman.name.
Results
The statistics for dispensed drug prescriptions during the
month of February 2006 (adjusted for 15/20 workdays)
comprised 41634 (adjusted to 31225) prescriptions.
46.0% consisted of new prescriptions (inter-pharmacy
range 42.8–50.0%). Of these new prescriptions, 52.4%
(inter-pharmacy range 38.0–74.6%) were transferred as
ePrescriptions (Table 1).
Clarification contacts were made for 2.0% (147/7532) of
new ePrescriptions and 1.2% (79/6833) of new non-elec-
tronic prescriptions. This resulted in an RR of 1.7 (95% CI
1.3–2.2) for new ePrescriptions compared to new non-
electronic prescriptions. The increased RR for ePrescrip-
tions was mainly due to one particular cause of interven-
tion. Namely, the 'Dosage and directions for use'. The RR
for this cause compared to other causes of intervention
was 7.6 (95% CI 2.8–20.4) (Table 2).
Of the 31225 dispensed prescriptions, 1.0% (312/31225)
necessitated a clarification contact with the prescriber.
These comprised 1.6% (226/14365) of all new prescrip-
tions and 0.5% (86/16860) of all refill prescriptions. This
yielded an RR of 3.1 (95% CI 2.4–4.0) for new prescrip-
tions compared to refill prescriptions (Table 2).
The prescribers accepted 89.5% of the suggested pharma-
cist interventions, 77.7% (192/247) as suggested and an
additional 11.7% (29/247) after a modification by the
prescriber during the contact (Table 3). Each prescription
necessitating a contact with a prescriber contains one or
more interventions.
When new and refill prescriptions were pooled together,
the median recorded duration of a contact with a pre-
scriber was lower for ePrescriptions (4 minutes) com-
pared to non-ePrescriptions (5 minutes).
Discussion
New ePrescriptions were associated with clarification con-
tacts to a greater extent than new non-electronic prescrip-
tions. This was mainly due to missing or ambiguous
information for 'Dosage and directions for use'. This may
be due to the widespread use of abbreviations, such as
'1t3d' (one tablet three times daily) which have not been
standardized among different EHRs. The abbreviations
may be translated by the EHRs in such a way that was
unanticipated by the prescribers prior to transferring the
prescription to the pharmacy. As only one in a hundred
prescriptions necessitated a prescriber contact, ePrescrip-
tions might still be more efficient and cost-effective over-
all compared to non-electronic prescriptions. However, if
the potential of ePrescriptions is to be fulfilled, quality
aspects must be more pronounced in future deployment.
ePrescribing in Sweden, has been subject to a low degree
of governmental regulation. Nevertheless, the technical
standards have been mutually agreed by all actors on a
national level. A need for more detailed standards has
been recognized, resulting in the implementation of a
standardized new ePrescription format (NEF). Also, a
Table 1: Number (percentage) of prescriptions dispensed during the study period (three weeks in February 2006).
All prescriptions
N = 31225
Refill prescriptions
N = 16860 (54.0%)
All new prescriptions
N = 14365 (46.0%)
New ePrescriptions N = 7532 (52.4%) New non-electronic Prescriptions N =
6833 (47.6%)
Pharmacy 1 5880 3127 (53.2%) 2055 (74.6%) 698 (25.3%)
Pharmacy 2 10472 5232 (50.0%) 3058 (58.4%) 2182 (41.6%)
Pharmacy 3 14873 8501 (57.2%) 2419 (38.0%) 3953 (62.0%)
Only ordinary drug prescriptions dispensed for humans are included. Monthly statistics are adjusted (15/20) for the three week period.
Source: Apoteket AB SwedenBMC Medical Informatics and Decision Making 2009, 9:8 http://www.biomedcentral.com/1472-6947/9/8
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national working party for modernization of ePrescribing
(MER) is developing next-generation applications. Some
of the weaknesses in the ePrescribing process detected in
the present study are expected to be improved with these
new standards. The introduction of an extensive electronic
process in health care involves a variety of different actors,
emphasizing the need for a national infrastructure for
continuous change management, including strategies,
policies, and implementation for improved quality and
safety.
The majority of the pharmacists' clarification contacts
were accepted by the prescribers, which is in accordance
with other studies [28]. This result emphasizes the bene-
fits of pharmacists as gatekeepers. It also underlines the
ongoing need for pharmacists to act in this area in order
to prevent the patient from incurring prescription errors.
If undiscovered, such errors may result in serious adverse
drug reactions and even hospitalization [29,30]. On the
other hand, there is an obvious benefit of designing the
different EHRs to minimize primary errors. Such a strategy
would also reduce the need for pharmacist intervention.
Table 2: Causes of clarification contacts, presented according to type of prescription, in three mail-order pharmacies over a three 
week period.
All prescriptions
(N = 31225)
Refill prescriptions
(N = 16860)
New ePrescriptions
(N = 7532)
New non-electronic 
prescriptions
(N = 6833)
Relative risk
(95% CI)
Number of prescriptions 
necessitating a clarification 
contact
312 86 147 79 1.7 (1.3–2.2)
Total number of causes of 
clarification contacts
348 103 150 95 -
Causes
Incorrect or incomplete 
prescribing
Drug, strength, dosage form 45 10 15 20 0.5 (0.3–0.9)
Dosage and directions for use 73 21 48 4 7.6 (2.8–20.4)
Quantity or duration of therapy 21 5 8 8 0.6 (0.3–1.6)
Other 39 8 14 17 0.5 (0.3–1.0)
Prescriber, patient, or discount 
information
23 2 7 14 0.3 (0.1–0.8)
Interactions
Drug-drug 6 3 2 1 1.3 (0.1–13.8)
Other causes
Adverse effects, toxicity, 
illegible prescription, falsified 
prescription, patients' 
concerns, missing date, or 
other
44 16 17 11 1.0 (0.5–2.0)
Drug temporarily unavailable or 
withdrawn from the market
97 38 39 20 1.2 (0.8–2.0)
Table 3: Results of suggested interventions per type of prescription.
Type of clarification contact All prescriptions Refill prescriptions New ePrescriptions New non-electronic prescriptions
Number (N = 312) % (N = 86) % (N = 147) % (N = 79) %
Contact with prescriber 247 79.2 64 74.4 123 83.7 60 75.9
- suggestion accepted 192 61.5 50 58.1 91 61.9 51 64.6
- suggestion accepted with 
modification
29 9.3 10 11.6 14 9.5 5 6.3
- suggestion not accepted 14 4.5 1 1.2 11 7.5 2 2.5
- other 10 3.2 2 2.3 7 4.8 1 1.3
Missing value 2 0.6 1 1.2 - - 1 1.3
Unsuccessful attempt to contact 
the prescriber
65 20.8 22 25.6 24 16.3 19 24.1BMC Medical Informatics and Decision Making 2009, 9:8 http://www.biomedcentral.com/1472-6947/9/8
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Limitations
In our study clarification contacts were detected for 0.5–
1.6% of the prescriptions. The proportion of prescription
errors seen in other studies varies between 0.9% and
8.7%. The largest value was detected at a mail-order phar-
macy [23,31-35]. The reasons for this wide range of per-
centage values may include differences in definitions,
methodology, culture, legislation and the technical solu-
tions available. One major reason for the rather low fre-
quency in our study compared to other studies may be
that we only included prescribing errors that the dispens-
ing pharmacists considered severe enough to necessitate a
clarification contact with the prescriber. For example, the
'dose and directions for use' texts were edited by pharma-
cists for readability and correctness to a much greater
extent than reported here.
One reason for the observed increased RR for ePrescrip-
tions compared to paper prescriptions could be that pre-
scribers who adopt new technology at an early phase
differ from their more cautious colleagues in terms of
carefulness and accuracy. The increased need for clarifica-
tion contacts with prescribers may also reflect a need for
more user training in the new technology.
The reported error rates in other studies employing self-
reported interventions have shown tenfold variation
which may indicate low validity. To ascertain a high
degree of capture we used independent observers to docu-
ment the interventions. The alignment of the work organ-
ization and the supervision of the protocol employed
were chosen in order to achieve consistent reporting
which minimized the inter-individual variation. Never-
theless, in observational studies the risk of misclassifica-
tion must be taken into account. We are of the opinion
that our results were not influenced to any considerable
extent by misclassification in the data gathered specifically
for the study. However, we cannot rule out the risk of mis-
classification in the statistical data acquired from
Apoteket AB. We made an attempt to evaluate the risk of
misclassification in a small sample (1 pharmacy, 2 days),
and found that in some cases refill prescriptions (< 5%)
could have been recorded as new prescriptions. A sensitiv-
ity analysis revealed that our risk estimate for ePrescrip-
tions, RR 1.7, could be a slight overestimate. An assumed
differential misclassification of 5% of the non-electronic
prescriptions yielded an RR of 1.5 (95% CI 1.1–1.9).
Improvement of quality and safety
Medical errors constitute one of the most important qual-
ity problems in health care today [36]. Studies have
shown that 2.4–7% of admissions to inpatient facilities
were caused by adverse drug reactions [37]. Of these, 50%
were deemed to be preventable [36]. Prescribing errors
comprise one important contributable cause to adverse
drug reactions. The reason for these unintended errors
might be due to imperfect user interface and design of the
ePrescribing computer systems.
The introduction of computerized prescribing was
expected to increase quality and safety for patients in
health care. Nevertheless, computerized order entry sys-
tems (CPOE) in hospitals have been shown to actually
facilitate medication errors [20]. The unintended conse-
quences of CPOE are widespread and can be both positive
and negative, and continue to exist over the duration of
use. Aggressive detection and management of adverse
unintended consequences is considered vital for CPOE
success [38]. By identifying and understanding the types
and causes of unintended adverse consequences associ-
ated with CPOE, system developers and implementers are
expected to better manage implementation and mainte-
nance of CPOE [39].
Increasingly, the prescription information entered by the
prescriber into the EHR will not be used solely for phar-
macy dispensing of prescriptions, but also by the patients
for medication lists and online medication history [40-
42]. The information will also be used for clinical decision
making by other  physicians and for epidemiological
research and evaluation. This underscores the need for
continuous monitoring of quality and improvement [22].
Future aspects
With the majority of prescriptions transferred as ePrescrip-
tions, there is an obvious need for improved evaluation
and certification of the information and communication
technology (ICT) systems which produce drug prescrip-
tions. Our study has highlighted a number of aspects of
ePrescribing in need of improvement. These aspects
should be followed up in subsequent studies. ICT systems
for ePrescribing must also be evaluated intermittently
with compulsory certification to assure patients of high
quality health care [21,43].
Conclusion
The increased proportion of prescriptions necessitating a
clarification contact for new ePrescriptions, compared to
new non-electronic prescriptions, indicates the need for
an increased focus on quality aspects in ePrescribing
deployment. ETP technology should be developed
towards a two-way communication between the pre-
scriber and the pharmacist with automated checks for
missing, inaccurate, or ambiguous information. Such a
process would increase safety and quality for the patient
and improve efficiency and cost-effectiveness within the
health care system.BMC Medical Informatics and Decision Making 2009, 9:8 http://www.biomedcentral.com/1472-6947/9/8
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